This session at ACR Convergence 2022, on Monday, Nov. 14, 2022, from 9–10 a.m. EST, will examine guidelines and current evidence regarding the management and outcomes of patients with ankylosing spondylitis (AS). Alexis Ogdie, MD, a rheumatologist and associate professor of Medicine at the University of Pennsylvania, Philadelphia, will present data to highlight the evolution of treatment strategies. The presentation will focus on evidence for state-of-the-art treatments in AS, including assessing whether treat to target is a paradigm that fits AS. The current state of evidence and what further studies will be useful to support or refute the use of treat to target in AS will be discussed.
Watch this space for our full report on this important session.